Transthyretin Amyloidosis (ATTR) Market Report

China Transthyretin Amyloidosis (ATTR) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 24, 2022
  • PAGES：178
  • REPORT CODE：GMM1137670
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Transthyretin Amyloidosis (ATTR) market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Transthyretin Amyloidosis (ATTR) market. Detailed analysis of key players, along with key growth strategies adopted by Transthyretin Amyloidosis (ATTR) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Alnylam Pharmaceuticals

    • Corino Therapeutics

    • Proclara Bioscience

    • Ionis Pharmaceuticals

    • Pfizer

    • Arcturus Therapeutics

    By Type:

    • Hereditary ATTR (HATTR)

    • Wild-Type (WT) ATTR

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Diagnostic Centers

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Transthyretin Amyloidosis (ATTR) Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Hereditary ATTR (HATTR) from 2016 to 2027

    • 1.3.2 China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Wild-Type (WT) ATTR from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Hospitals from 2016 to 2027

    • 1.4.2 China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027

    • 1.4.3 China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Diagnostic Centers from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Transthyretin Amyloidosis (ATTR) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Transthyretin Amyloidosis (ATTR) by Major Types

    • 3.4.1 Market Size and Growth Rate of Hereditary ATTR (HATTR)

    • 3.4.2 Market Size and Growth Rate of Wild-Type (WT) ATTR

    4 Segmentation of Transthyretin Amyloidosis (ATTR) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Transthyretin Amyloidosis (ATTR) by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Transthyretin Amyloidosis (ATTR) in Hospitals

    • 4.4.2 Market Size and Growth Rate of Transthyretin Amyloidosis (ATTR) in Ambulatory Surgical Centers

    • 4.4.3 Market Size and Growth Rate of Transthyretin Amyloidosis (ATTR) in Diagnostic Centers

    5 Market Analysis by Regions

    • 5.1 China Transthyretin Amyloidosis (ATTR) Production Analysis by Regions

    • 5.2 China Transthyretin Amyloidosis (ATTR) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Transthyretin Amyloidosis (ATTR) Landscape Analysis

    • 6.1 North China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major Types

    • 6.2 North China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major End-Users

    7 Central China Transthyretin Amyloidosis (ATTR) Landscape Analysis

    • 7.1 Central China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major Types

    • 7.2 Central China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major End-Users

    8 South China Transthyretin Amyloidosis (ATTR) Landscape Analysis

    • 8.1 South China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major Types

    • 8.2 South China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major End-Users

    9 East China Transthyretin Amyloidosis (ATTR) Landscape Analysis

    • 9.1 East China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major Types

    • 9.2 East China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major End-Users

    10 Northeast China Transthyretin Amyloidosis (ATTR) Landscape Analysis

    • 10.1 Northeast China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major Types

    • 10.2 Northeast China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major End-Users

    11 Southwest China Transthyretin Amyloidosis (ATTR) Landscape Analysis

    • 11.1 Southwest China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major Types

    • 11.2 Southwest China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major End-Users

    12 Northwest China Transthyretin Amyloidosis (ATTR) Landscape Analysis

    • 12.1 Northwest China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major Types

    • 12.2 Northwest China Transthyretin Amyloidosis (ATTR) Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Alnylam Pharmaceuticals

      • 13.1.1 Alnylam Pharmaceuticals Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Corino Therapeutics

      • 13.2.1 Corino Therapeutics Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Proclara Bioscience

      • 13.3.1 Proclara Bioscience Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Ionis Pharmaceuticals

      • 13.4.1 Ionis Pharmaceuticals Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Pfizer

      • 13.5.1 Pfizer Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Arcturus Therapeutics

      • 13.6.1 Arcturus Therapeutics Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Hereditary ATTR (HATTR) from 2016 to 2027

    • Figure China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Wild-Type (WT) ATTR from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027

    • Figure China Transthyretin Amyloidosis (ATTR) Market Size and Growth Rate of Diagnostic Centers from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Transthyretin Amyloidosis (ATTR) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Transthyretin Amyloidosis (ATTR) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Transthyretin Amyloidosis (ATTR)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Transthyretin Amyloidosis (ATTR) by Different Types from 2016 to 2027

    • Table Consumption Share of Transthyretin Amyloidosis (ATTR) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Hereditary ATTR (HATTR)

    • Figure Market Size and Growth Rate of Wild-Type (WT) ATTR

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Transthyretin Amyloidosis (ATTR) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Transthyretin Amyloidosis (ATTR) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Ambulatory Surgical Centers

    • Figure Market Size and Growth Rate of Diagnostic Centers

    • Table China Transthyretin Amyloidosis (ATTR) Production by Regions

    • Table China Transthyretin Amyloidosis (ATTR) Production Share by Regions

    • Figure China Transthyretin Amyloidosis (ATTR) Production Share by Regions in 2016

    • Figure China Transthyretin Amyloidosis (ATTR) Production Share by Regions in 2021

    • Figure China Transthyretin Amyloidosis (ATTR) Production Share by Regions in 2027

    • Table China Transthyretin Amyloidosis (ATTR) Consumption by Regions

    • Table China Transthyretin Amyloidosis (ATTR) Consumption Share by Regions

    • Figure China Transthyretin Amyloidosis (ATTR) Consumption Share by Regions in 2016

    • Figure China Transthyretin Amyloidosis (ATTR) Consumption Share by Regions in 2021

    • Figure China Transthyretin Amyloidosis (ATTR) Consumption Share by Regions in 2027

    • Table North China Transthyretin Amyloidosis (ATTR) Consumption by Types from 2016 to 2027

    • Table North China Transthyretin Amyloidosis (ATTR) Consumption Share by Types from 2016 to 2027

    • Figure North China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2016

    • Figure North China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2021

    • Figure North China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2027

    • Table North China Transthyretin Amyloidosis (ATTR) Consumption by End-Users from 2016 to 2027

    • Table North China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users from 2016 to 2027

    • Figure North China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2016

    • Figure North China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2021

    • Figure North China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2027

    • Table Central China Transthyretin Amyloidosis (ATTR) Consumption by Types from 2016 to 2027

    • Table Central China Transthyretin Amyloidosis (ATTR) Consumption Share by Types from 2016 to 2027

    • Figure Central China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2016

    • Figure Central China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2021

    • Figure Central China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2027

    • Table Central China Transthyretin Amyloidosis (ATTR) Consumption by End-Users from 2016 to 2027

    • Table Central China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2016

    • Figure Central China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2021

    • Figure Central China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2027

    • Table South China Transthyretin Amyloidosis (ATTR) Consumption by Types from 2016 to 2027

    • Table South China Transthyretin Amyloidosis (ATTR) Consumption Share by Types from 2016 to 2027

    • Figure South China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2016

    • Figure South China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2021

    • Figure South China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2027

    • Table South China Transthyretin Amyloidosis (ATTR) Consumption by End-Users from 2016 to 2027

    • Table South China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users from 2016 to 2027

    • Figure South China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2016

    • Figure South China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2021

    • Figure South China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2027

    • Table East China Transthyretin Amyloidosis (ATTR) Consumption by Types from 2016 to 2027

    • Table East China Transthyretin Amyloidosis (ATTR) Consumption Share by Types from 2016 to 2027

    • Figure East China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2016

    • Figure East China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2021

    • Figure East China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2027

    • Table East China Transthyretin Amyloidosis (ATTR) Consumption by End-Users from 2016 to 2027

    • Table East China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users from 2016 to 2027

    • Figure East China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2016

    • Figure East China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2021

    • Figure East China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2027

    • Table Northeast China Transthyretin Amyloidosis (ATTR) Consumption by Types from 2016 to 2027

    • Table Northeast China Transthyretin Amyloidosis (ATTR) Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2016

    • Figure Northeast China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2021

    • Figure Northeast China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2027

    • Table Northeast China Transthyretin Amyloidosis (ATTR) Consumption by End-Users from 2016 to 2027

    • Table Northeast China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2016

    • Figure Northeast China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2021

    • Figure Northeast China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2027

    • Table Southwest China Transthyretin Amyloidosis (ATTR) Consumption by Types from 2016 to 2027

    • Table Southwest China Transthyretin Amyloidosis (ATTR) Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2016

    • Figure Southwest China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2021

    • Figure Southwest China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2027

    • Table Southwest China Transthyretin Amyloidosis (ATTR) Consumption by End-Users from 2016 to 2027

    • Table Southwest China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2016

    • Figure Southwest China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2021

    • Figure Southwest China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2027

    • Table Northwest China Transthyretin Amyloidosis (ATTR) Consumption by Types from 2016 to 2027

    • Table Northwest China Transthyretin Amyloidosis (ATTR) Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2016

    • Figure Northwest China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2021

    • Figure Northwest China Transthyretin Amyloidosis (ATTR) Consumption Share by Types in 2027

    • Table Northwest China Transthyretin Amyloidosis (ATTR) Consumption by End-Users from 2016 to 2027

    • Table Northwest China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2016

    • Figure Northwest China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2021

    • Figure Northwest China Transthyretin Amyloidosis (ATTR) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Alnylam Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

    • Table Product and Service Introduction of Alnylam Pharmaceuticals

    • Table Company Profile and Development Status of Corino Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Corino Therapeutics

    • Figure Sales and Growth Rate Analysis of Corino Therapeutics

    • Figure Revenue and Market Share Analysis of Corino Therapeutics

    • Table Product and Service Introduction of Corino Therapeutics

    • Table Company Profile and Development Status of Proclara Bioscience

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Proclara Bioscience

    • Figure Sales and Growth Rate Analysis of Proclara Bioscience

    • Figure Revenue and Market Share Analysis of Proclara Bioscience

    • Table Product and Service Introduction of Proclara Bioscience

    • Table Company Profile and Development Status of Ionis Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ionis Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ionis Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ionis Pharmaceuticals

    • Table Product and Service Introduction of Ionis Pharmaceuticals

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Arcturus Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arcturus Therapeutics

    • Figure Sales and Growth Rate Analysis of Arcturus Therapeutics

    • Figure Revenue and Market Share Analysis of Arcturus Therapeutics

    • Table Product and Service Introduction of Arcturus Therapeutics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US